>AntiCD28 VH
EVKLLQSGGGLVTPGGSLRIACVVSGFSLSDYGVHWVRQAPGQGLEWLSVIWAGGGTNYADSVMDRKSISRDNCKSSVFLKMNSLQVDDTAVYYCARDKGYSYYYSMDYWGQGTLVTVSS
>AntiCD28 VL
DIETLQSPDSLAVSLGERATINCRSSESVEYYVTSLLAWYQQKPGQPPKLLIFAASARESGVPDRFSGSGSGTNFSLTIHPVQEDDVAMYFCQQSRKYVPYTFGGGTKLEIK
>Campath VH
QVKLLESGPGLVKPSETMRLTCAGSGFTFTDFYWNWIRQPAGKAPEWLGFIRDKAKGYTTEYNPSLKGRFTISVDTTQNMFSLQMNTVTAADTATYYCAREGHTAAPFDYWGQGVMVTVSS
>Campath VL
DIKMTQSPSFLSASVGDRVTLNCQASQNIDKYLNWYQQKLGESPKLLIYNTNNLQTGVPSRFSGSGSGTDFTLTISSLQPEDVATYFCLQHISRPRTFGTGTKLEIK
>Bevacizumab VH
EIQLVQSGGGLKQPGGTLRISCVASGYTFTNYGMNWVAQAPGKGLKWMSWINTYTGEPTYAASVKRRFTISLETSKSTAYLQISNLRNDDTAVYFCAKYPHYYGSSHWYFDVWGKGTTVTVSS
>Bevacizumab VL
DIQMTQTPSSLSASVGDRVIISCQASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFSLTISNLQPEDIATYYCQQYSTVPWTFGGGTKLEIK
>Herceptin VH
QVQLLESGGALVKPGGSLRLSCAASGFNIKDTYIHWVRQAPGQGLVWVSRIYPTNGYTRYADSAEDRDTITRDSSKNTMYLQVNRLTVEDTAVYYCSRWGGDGFYAMDYWGQGALVTVSS
>Herceptin VL
DIQMTQSHSFMSTSVGDRVSITCRASQDVNTAVNWYQQKPGHAPKLLIYSASFLYTGVPSRFTGNRSGTDFTFTISSVQAEDLATYYCQQHYTTPPTFGGGTKVEIK
>Omalizumab VH
DVQLLESGGGLVKPGGSLRLACSVAGYSITSGYSWNWIRQAPGAKLEWVSSITYDGSSNYADSVKNRFSVSRDGSQNSFFLKMNSATAEDTAVYYCARGSHYFGHWHFAVWGRGTAVTVSS
>Omalizumab VL
DIQLTQSPSSLSASVGDRATITCRASQSVDYDGDSYLNWYQQKPGKAPILLIYAASYLQSEVPSRFSGSGSGTDFTLNIHSLQPEDFATFYCQQSHEDPYTFGAGTKVEIK
>Eculizumab VH
QVQLVQSGAEVKKPGASVKVSCKATGYIFSNYWIQWIRQAPGHGLEWMGWILPGSGSTEYTENFQDRVAFTADTSINTAYMELSSLTSEDTAVYYCARYFFGSSPNWYFDVWGCGTTVTVSS
>Eculizumab VL
DIQMTQSPSSLSASVGDRVTITCRASENIYGALNWYQRKPGKAPQLLIYGATNLQDGVSSRFSGSGSGTQFYLTISSLHPDDVATYYCQNVLNTPLTFGQGTKLELK
>Tocilizumab VH
QLQLQESGPVLVKPSETLSLTCTVSGYSITSDHAWSWIRQPPGKGLEWIGYISYSGITTYNPSLKSRASITVDTSKNQFSLQLNSVTAGDTSVYYCARSLARTTAMDYWGQGTSVTVSS
>Tocilizumab VL
DIQMTQTTSSLSASVGDRVTISCRASQDISSYLNWYQQKPDKAPKLLIYYTSRLQSGVPSRFSGSGSGTDFSLTINNLQQEDIATYFCQQGNTLPYTFGQGTRLEIN
>Pembrolizumab VH
QVQLVQPGAEVKKPGTSVKLSCKASGYTFTNYYMYWVRQAPGQGLEWMGGINPSNGGTNFAEKFQNKVTLTVDSSISTTYMELSSLTSEDSAVYYCTRRDYRFDMGFDYWGQGTTLTVSS
>Pembrolizumab VL
EIVLTQSPATLAVSPGERAALSCRASKGVSTSGYSYLAWYQQKPGQSPRLLIYLASYWASGVPARFSGSGSGTDFTLNIHSLEEEDFATYYCQHSRDLPLTFGTGTKLELK
>Pertuzumab VH
EVQLLQSGGTLVKPGGSLRISCVASGFTFTDYTMDWVRQAHGKSLEWVSDVNPNSGGSIYAQRGKGRFSLSVDRSKRIVYMEMRSLTFEDTAVYYCARNLGPSFYFDYWGQGTTVTVSS
>Pertuzumab VL
DTQMTQSHSIMSASVGDRVSITCRASQDVSIGVAWYQQRPGQAPKLLIYSASYLYTGVPSRFTGSGSGTDFTFTISSLQPEDLATYYCQQYYIYPYTFGGGTKLEIK
>Ixekizumab VH
QVQLVQSRAEVKKPGASVKISCKASGYSFTDYNMNWVRQANGKSLEWMGVINPNYGTTDYAQRFQGKVTLTVDQSIRTAYMELNSLTSEDSAVYYCVIYDYATGTGGYWGQGSPLTVSS
>Ixekizumab VL
DVVLTQSPLSLPVTLGQPASISCRSSQSLVHSNGNTYLHWYLQRPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPFTFGQGTKLEIK
>Palivizumab VH
QIELQESGPTLVKPTQTLTLTCSFSGFSLSTSGMSVGWIRQPPGEALEWLADIWWDDKKDYNPSLKSRLTISKDTSSNQVVLTITGVDPADTATYYCARSMITNWYFDVWGAGTTVTVSS
>Palivizumab VL
DIQLTQSPSTMSASVGERVTMTCRASSSVGYLHWYQQKSSTAPKLLIYDTSKLQSGVPGRFSGSGSGNEFTLTISSIQPEDVATYYCFQGSGYPFTFGQGTKLEIK
>Certolizumab VH
QIQLVQSGGDLKQPGEYVRISCAASGYVFTDYGMNWVRQAPGKAFKWLSWINTYIGEPIYVDSVKGRFAFSRETSKNTLFLQINNLKAEDTAVYFCARGYRSYAMDYWGQGTLVTVSS
>Certolizumab VL
DIQMTQSQSFMSASVGDRVSVTCRASQNVGTNVAWYQQKPGQAPKALIYSASFLQSGVPYRFTGSGSGTDFTLTISTLQPEDLATYFCQQYNIYPLTFGQGTKLELK
>Idarucizumab VH
QVQLQQWGPGLVAPSETLSLTCTVSGFSLTSYIWDWIRQSPGKGLEWLGVIWAGGSTGYNSALRSRVSITVSTSKSQVSLQMNSVTAADTAIYYCASAAYYSYYNYDGFAYWGQGTLVTVSA
>Idarucizumab VL
DVVMTQSPLSLSVTPGQPASISCKSSQSLLYTNGKTYLYWFLQRPGQSPRRLIYLVSKRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGIYYCLQSTHFPHTFGGGTKLEIK
>Reslizumab VH
EVKLLESGGGLVQPGGTLRLTCTVSGLSLTSNSVNWIRQAPGKGLEWMSLIWSNGDTDYASAIKSRLSISRDTSKNSVFLKMNSLRVEDTAMYFCAREYYGYFDYWGQGVMVTVSS
>Reslizumab VL
DIQMTQSPASLSASLGDRISIECLASEGISSYLAWYQQKPGKAPQLLIYGANSLQTGVPSRFSGSGSATQFSLTISSMQPEDEGDYFCQQSYKFPNTFGQGTKLELK
>Solanezumab VH
QVKLVESGGGVVQPGGSLRLSCAVSGFTFSRYSMSWVRQAPGKGLELVSQINSVGNSTYYADTVKGRFTISRDNAEYTLSLQMSGLRVDDTAVYYCASGDYWGQGTTLTVSS
>Solanezumab VL
DVVMTQTPLSLPVTLGQPASISCRSSQSLIYSDGNAYLHWFLQRPGQSPRLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVETEDVGVYYCSQSTHVPWTFGQGTKLEIK
>Lorvotuzumab VH
QVQLVESGGGVVQPGGSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVSYISSGSFTIYHADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAHYYCARMRKGYAMDYWGQGTLVTVSS
>Lorvotuzumab VL
DVLMTQSPLSLPVTLGQPASISCRSSQIIIHSDGNTYLYWFQQRPGQSPQRLIYKVSNRFSGVPDRFSGSGSGTDFTLMISRVEAEDVGVYYCFQGSHVPHTFGQGTKLEIK
>Pinatuzumab VH
QVQLVQSGGELIQPGGSLRISCVASGYEFSRSWMNWVRQAPGQGREWVSRIYPGDGDTNYSGSFKGAFTLSRDKSKSTLYMQMSSLTVVDTAVYFCARDGSSWDWYFDVWGCGTTVTVSS
>Pinatuzumab VL
AIQMTQSPSTLPASVGDRASISCRASQSIVHSNGNTFLEWYLQKPGKAPKLLIYKVSNLQSGVPSRFSGSGSGTDFTLTISRLQPEDLGTYYCFQGSQFPYTFGGGTKVEIK
>Etaracizumab VH
QVQLLESGGGLVKPGGSLRLSCAASGFAFSSYDMSWVRQIPGKGLEWVSKVSSGGGSTYYADFVQGRFTISRDNAKNTLYLQMNSLNVEDTAVYYCARHNYGSFAYWGQGTLVTVSS
>Etaracizumab VL
ELVMTQTPATLSVSPGDSASLSCRASQSISNHLAWYQQKSGQSPRLLIYYASFRASGIPARFSGSGSGTDFTLSINSLETEDFAMYYCQQSNSWPHTFGGGTKLEIK
>Talacotuzumab VH
EVQLVQSGAEVKKPGESLKMSCKASGYTFTDYYIGWVRQSHGKSLEWIGDIIPSNGATFYNQSFQGQVTLSVDRSISTAYMHWNSLTASDSAVYYCTRSHLLRASWFAYWGQGTLVTVSA
>Talacotuzumab VL
DFVMTQSPDSLTVALGERATFNCKSSQSLLNSGNQKNYLTWYLQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQPEDVAVYYCQNDYSYPYTFGGGTKLEIK
>Rovalpituzumab VH
QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLKWMAWINTYTGEPKYAQDFQGQVAMTAETSISTASMEIINLKAEDTAVYFCARIGDSSPSDYWGQGTTLTVSS
>Rovalpituzumab VL
EIVLTQTPGTLSVSAGDRATLTCKASQSVSNDAVWYQQKPGQSPRLLIYYASNRATGVPDRFAGSGYGTDFSLTISTLEAEDFAVYFCQQDYTSPWTFGGGTKLEIR
>Clazakizumab VH
QSLEESGGRLVTPGGSLRLTCAASGFSLSNYYVTWVRQAPGKGLEWISIIYGSDETAYATWAIGRFTISKTSTTVDLKMTSLRAADTAVYFCARDDSSDWDAKFNLWGQGTLVTVSS
>Clazakizumab VL
AYDMTQTPASVSAAVGGRVTIKCQASQSINNELSWYQQKPGQAPKLLIYRASTLQSGVSSRFKGSGSGTEFTLTISDLQCADAATYYCQQGYSLRNIDNAFGGGTEVVVK
>Ligelizumab VH
QVQLVQSGAEVKKPGASVKVSCKTTGYTFSMYWLEWVRQAPGHGLEWVGEISPGTFTTNYAEKFQAKVTFTADTSINTAYLELSGLTSEDSAVYFCARFSHFSGSNYDYFDYWGQGTSLTVSS
>Ligelizumab VL
EILLTQSPAILSVSPGERATFSCRASQSIGTNLAWYQQRTDQSPRLLIYYASESATGIPARFSGSGSGTEFTLNINSVESEDIAVYYCQQSDSWPTTFGGGTKLEIK
>Crizanlizumab VH
QVQLVQSGPEVKKPGALVKISCKASGYTFTSYDINWVRQAPGQGLEWMGWIYPGDGSIKYAEKFQGKATLTVDKSISTAYMEVSSLTSENMAVYFCARRGEYGNYEGAMDYWGQGTTVTVSS
>Crizanlizumab VL
DIQLTQSPSSLSASVGDRATITCQASQSVDYDGHSYLNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLNIHSLQPEDFATYYCQQSDENPLTFGTGTRVELK
>Mogamulizumab VH
QVQLVESGGDLMKPGGSLRISCAASGFIFSNYGMSWVRQTPGMGLEWVATISSASTYSYYADSVKGRFTISRDNAENSLYLQMNSLRVEDTGIYYCGRHSDGNFAFGYWGRGTLVTVSA
>Mogamulizumab VL
DVLMTQTPLSLPVTLGQPASISCRSSRNIVHINGDTYLEWYLQRPGQSPRLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSLLPWTFGQGTRLEIR
>Refanezumab VH
QVQLVQSGSELKKPGASNKVSCKASGYTFTNYGMNWVRQAPGKGLEWMGWINTYTGEPTYAQGFTGRFVFSLDTSASTAYLQISNLKAEDTAVYYCARNPINYYGINYEGYVMDYWGQGTLVTVSS
>Refanezumab VL
DIVMSQSPDSLAVSLGERATINCKSSHSVLYSSNQKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTIINLHTEDVAVYYCHQYLSSLTFGTGTKLEIK
